James Thrasher MD Fellow American College of Endocrinology

Endocrinology•Little Rock, AR

Diabetes, Parathyroid, Thyroid

CEO, Endocrinologist, Arkansas Diabetes and Endocrinology Center

Join to View Full Profile

11400 Huron LnLittle Rock, AR 72211
Phone+1 501-666-3666
Fax+1 501-907-9069

Education & Training

University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Internal Medicine, 1996 - 1999
University of Arkansas For Medical Sciences College of MedicineClass of 1996

Certifications & Licensure

AR State Medical License 1998 - 2026
MI State Medical License 2000 - 2004
American College of EndrocrinologyFellow of the American College of Endocrinology

Awards, Honors, & Recognition

Diabetes Recognition Program National Committee for Quality Assurance (NCQA)
Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Fellow (FACE) American Association of Clinical Endocrinology

Clinical Trials

Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide) Start of enrollment: 2010 Jun 01
Completed
Phase 3
Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results Start of enrollment: 2010 Aug 31
Completed
Phase 3
CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes Start of enrollment: 2010 Nov 11
Completed
Phase 3
Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND) Start of enrollment: 2011 Jul 22
Completed
Phase 3
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Mellitus on Basal Plus Mealtime Insulin Start of enrollment: 2011 Dec 01
Completed
Phase 3
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Basal Insulin With Oral Antidiabetic Therapy Start of enrollment: 2011 Dec 01
Completed
Phase 3
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy Start of enrollment: 2012 Aug 01
Completed
Phase 3
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus Start of enrollment: 2012 Sep 01
Completed
Phase 3
Efficacy and Safety of Lixisenatide Versus Placebo on Top of Basal Insulin and/or Oral Antidiabetic Treatment in Older Type 2 Diabetic Patients Start of enrollment: 2013 Jun 01
Completed
Phase 3
A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects With Type 2 Diabetes at High Risk of Cardiovascular Events Start of enrollment: 2013 Oct 29
Completed
Phase 3
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data Start of enrollment: 2013 Nov 26
Completed
Not Applicable
Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes Start of enrollment: 2014 Nov 11
Completed
Phase 3
Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine Start of enrollment: 2014 Oct 01
Completed
Phase 3
Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 2 Diabetes Mellitus Also Using Insulin Glargine Start of enrollment: 2015 Jan 01
Completed
Phase 3
Assessment of the Safety of SAR342434 and Humalog® When Administered as Continuous Subcutaneous Insulin Infusion Start of enrollment: 2015 Nov 01
Completed
Phase 1
A Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 Diabetes Start of enrollment: 2017 Jan 17
Completed
Phase 3
Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to SGLT-2i in Subjects With Type 2 Diabetes Mellitus Start of enrollment: 2017 Mar 15
Completed
Phase 3
A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes Start of enrollment: 2019 Jun 17
COMPLETED
PHASE3
Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System Start of enrollment: 2019 Jul 24
COMPLETED
NA
Cigarette Pack Inserts for Smoking Cessation Start of enrollment: 2019 Aug 01
Completed
Not Applicable
An Open-label, Two-center, Randomized, Cross-over Study to Evaluate the Safety and Efficacy of Glycemic Control Using Hybrid-closed Loop vs. Advanced Hybrid Closed-loop in Young Subjects With Type 1 Diabetes Start of enrollment: 2020 Jul 19
Completed
Not Applicable
Evaluation of the MiniMed™ 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp® Start of enrollment: 2022 Mar 17
COMPLETED
NA
In-Home Study With MiniMed™ 780G Pump Automated Control in Type 2-Evaluation of the AHCL System in Adults With Insulin-requiring Type 2 Diabetes Start of enrollment: 2022 Feb 25
COMPLETED
NA
Join now to see all

Publications & Presentations

PubMed

1 citations
Safety and Effectiveness of MiniMed™ 780G Advanced Hybrid Closed-Loop Insulin Intensification in Adults with Insulin-Requiring Type 2 Diabetes.
Anuj Bhargava, Richard M Bergenstal, Mark L Warren, James R Thrasher, Michael A Dempsey
Diabetes Technology & Therapeutics. 2025-02-06
7 citations
Early Real-World Performance of the MiniMed™ 780G Advanced Hybrid Closed-Loop System and Recommended Settings Use in the United States.
James R Thrasher, Arcelia Arrieta, Fang Niu, Katherine R Cameron, Toni L Cordero
Diabetes Technology & Therapeutics. 2024-03-01
Chapter 4: Summary and a Patient Perspective on Living with Heart Failure.
Rhonda E Monroe, James Thrasher
The American Journal of Medicine. 2024-02-01

Press Mentions

Insulin Aspart Biosimilar Safe for Pump Therapy Use in Type 1 DiabetesFebruary 7th, 2020
New Real-World Data Shows MiniMed™ 780G System Sustains Strong Global Performance, Exceeding International Targets for Diabetes ManagementMarch 12th, 2024

Grant Support

Building Stochastic Actor-Oriented Models to investigate social network influences on youth nicotine product use transitions and to simulate different intervention effects across contextsUNIVERSITY OF SOUTH CAROLINA AT COLUMBIA2024–2029
Building Stochastic Actor-Oriented Models to investigate social network influences on youth nicotine product use transitions and to simulate different intervention effects across contextsUNIVERSITY OF SOUTH CAROLINA AT COLUMBIA2024–2029
Building Stochastic Actor-Oriented Models to investigate social network influences on youth nicotine product use transitions and to simulate different intervention effects across contextsUNIVERSITY OF SOUTH CAROLINA AT COLUMBIA2024–2029
Building Stochastic Actor-Oriented Models to investigate social network influences on youth nicotine product use transitions and to simulate different intervention effects across contextsUNIVERSITY OF SOUTH CAROLINA AT COLUMBIA2024–2029
SRNT 2024 Annual Meeting Global SupportSOCIETY FOR RESEARCH ON NICOTINE/TOBACCO2024–2025
Evaluating nutrition labeling policy changes in the US and Mexico.UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA2021–2025
Evaluating nutrition labeling policy changes in the US and Mexico.UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA2021–2025
Evaluating nutrition labeling policy changes in the US and Mexico.UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA2021–2025
Evaluating nutrition labeling policy changes in the US and Mexico.UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA2021–2025
Evaluating nutrition labeling policy changes in the US and Mexico.UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA2021–2025
Evaluation of cigarette package inserts for enhanced communication with smokersUNIVERSITY OF SOUTH CAROLINA AT COLUMBIA2019–2024

Committees

Medtronic Hybrid Closed Loop (Artificial Pancreas) Studies Adult and Pediatric, Data Monitoring Board 2016 - 2022

Professional Memberships

Other Languages

French, German, Russian

External Links

Facebookhttps://www.facebook.com/Arkansas-Diabetes-and-Endocrinology-Center-876051319176481/?ref=bookmarks
Websitehttps://www.adeclittlerock.com

James Thrasher MD Fellow American College of Endocrinology

Dr. Thrasher is on Doximity

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Clinical Trials

Publications & Presentations

Press Mentions

Grant Support

Committees

Professional Memberships

Other Languages

External Links

Viewing the full profile is available to verified healthcare professionals only.